Adams, J. & Scott, J. (2000) Predicting medication adherence in severe mental disorders. Acta Psychiatrica Scandinavica, 101, 119–124.
Aikens, J. E., Nease, D. E. Jr, Nau, D. P.
et al (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Annals of Family Medicine, 3, 23–30.
Angermeyer, M. C., Loffler, W., Muller, P.
et al (2001) Patients' and relatives' assessment of clozapine treatment. Psychological Medicine, 31, 509–517.
Ayalon, L., Arean, P. A. & Alvidrez, J. (2005) Adherence to antidepressant medications in black and Latino elderly patients. American Journal of Geriatric Psychiatry, 13, 572–580.
Barber, N., Parsons, J., Clifford, S.
et al (2004) Patients' problems with new medication for chronic conditions. Quality and Safety in Health Care, 13, 172–175.
Batel, P., Reynaud-Maurupt, C., Lavignasse, P.
et al (2004) [Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts]. Presse Medicale, 33, 5–9.
Bayle, F. J., Chauchot, F., Maurel, M.
et al (1999) Survey on the announcement of schizophrenia diagnosis in France. L'Encephale, 25, 603–611.
Bowden, C. L., Collins, M. A., McElroy, S. L.
et al (2005) Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology, 30, 1932–1939.
Brown, K. W., Billcliff, N. & McCabe, E. (2001) Informed consent to medication in long-term psychiatric in-patients. Psychiatric Bulletin, 25, 132–134.
Bull, S. A., Hu, X. H., Hunkeler, E. M.
et al (2002a) Discontinuation of use and switching of antidepressants: influence of patient–physician communication. JAMA, 288, 1403–1409.
Bull, S. A., Hunkeler, E. M., Lee, J. Y.
et al (2002b) Discontinuing or switching selective serotonin-reuptake inhibitors. Annals of Pharmacotherapy, 36, 578–584.
Bultman, D. C. & Svarstad, B. L. (2000) Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Education and Counseling, 40, 173–185.
Bultman, D. C. & Svarstad, B. L. (2002) Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. Journal of the American Pharmaceutical Association, 42, 36–43.
Claxton, A. J., Cramer, J. & Pierce, C. (2001) A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23, 1296–1310.
Cochran, S. (1986) Compliance with lithium regimens in the outpatient treatment of bipolar affective disorder. Journal of Compliance in Health Care, 1, 153–170.
Col, N., Fanale, J. E. & Kronholm, P. (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Archives of Internal Medicine, 150, 841–845.
Colom, F., Vieta, E., Martinez-Aran, A.
et al (2000) Clinical factors associated with treatment noncompliance in euthymic bipolar patients. Journal of Clinical Psychiatry, 61, 549–555.
Cramer, J. A. & Rosenheck, R. (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196–201.
Daltroy, L., Katz, J., Morlino, C.
et al (1991) Improving doctor patient communication. Psychiatric Medicine, 2, 31–35.
Demyttenaere, K. (1998) Noncompliance with antidepressants: who's to blame?
International Clinical Psychopharmacology, 13 (suppl. 2), S19–25.
Demyttenaere, K., Enzlin, P., Dewe, W.
et al (2001) Compliance with antidepressants in a primary care setting. 1: Beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry, 62 (suppl. 22), 30–33.
Eaddy, M., Grogg, A. & Locklear, J. (2005) Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clinical Therapeutics, 27, 263–272.
Fakhoury, W. K. (1999) Extent of distress caused by adverse experiences associated with anti-psychotic treatment (abstract). European Neuropsychopharmacology, 9 (suppl. 5), S131–S390.
Fakhoury, W. K., Wright, D. & Wallace, M. (2001) Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology, 16, 153–162.
Fenton, W. S., Blyler, C. R. & Heinssen, R. K. (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin, 23, 637–651.
Garfield, S., Francis, S. A. & Smith, F. J. (2004) Building concordant relationships with patients starting antidepressant medication. Patient Education and Counseling, 55, 241–246.
Gilmer, T. P., Dolder, C R., Lacro, J. P.
et al (2004) Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692–699.
Gonzalez, J., Williams, J., Noel, P.
et al (2005) Adherence to mental health treatment in a primary care clinic. Journal of the American Board of Family Practice, 18, 87–96.
Grasso, B. C., Genest, R., Jordan, C. W.
et al (2003) Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatric Services, 54, 677–681.
Gray, R., Rofail, D., Allen, J.
et al (2005) A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing, 52, 31–37.
Greil, W. & Kleindienst, N. (1999) Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. International Clinical Psychopharmacology, 14, 283–285.
Haynes, R., McDonald, H. & Garg, A. (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, issue 2. Update Software.
Herbeck, D. M., Fitek, D. J., Svikis, D. S.
et al (2005) Treatment compliance in patients with comorbid psychiatric and substance use disorders. American Journal on Addictions, 14, 195–207.
Hogman, G. & Sandamas, G. (2000) A Question of Choice. National Schizophrenia Fellowship.
Irani, F., Dankert, M., Brensinger, C.
et al (2004) Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology, 29, 960–968.
Irvine, J., Baker, B., Smith, J.
et al (1999) Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Psychosomatic Medicine, 61, 566–575.
Johnson, D. A. (1981) Depression: treatment compliance in general practice. Acta Psychiatrica Scandinavica Supplementum, 290, 447–453.
Johnson, R. E. & McFarland, B. H. (1996) Lithium use and discontinuation in a health maintenance organization. American Journal of Psychiatry, 153, 993–1000.
Joyce, C. R., Caple, G., Mason, M.
et al (1969) Quantitative study of doctor–patient communication. Quarterly Journal of Medicine, 38, 183–194.
Kang, S., Kim, H., Kim, C.
et al (2005) Antipsychotic compliance and maintenance dosage in admitted patients with schizophrenia who had been followed up over 6 months. European Neuropsychopharmacology, 15, S490.
Kaplan, S. H., Greenfield, S., Gandek, B.
et al (1996) Characteristics of physicians with participatory decision-making styles. Annals of Internal Medicine, 124, 497–504.
Kasper, J. A., Hoge, S. K., Feucht-Haviar, T.
et al (1997) Prospective study of patients' refusal of antipsychotic medication under a physician discretion review procedure. American Journal of Psychiatry, 154, 483–489.
Kelly, G., Maimon, J. & Scott, J. (1987) Utility of the health belief model in examining medication compliance among psychiatric outpatients. Social Science and Medicine, 25, 1205–1211.
Lambert, M., Conus, P., Eide, P.
et al (2004) Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry, 19, 415–422.
Laurila, J. V., Pitkala, K. H., Strandberg, T. E.
et al (2004) Detection and documentation of dementia and delirium in acute geriatric wards. General Hospital Psychiatry, 26, 31–35.
Lewis-Fernandez, R., Das, A. K., Alfonso, C.
et al (2005) Depression in US Hispanics: diagnostic and management considerations in family practice. Journal of the American Board of Family Practice, 18, 282–296.
Lieberman, J. A., Stroup, T. S., McEvoy, J. P.
et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–1223.
Loffler, W., Kilian, R., Toumi, M.
et al (2003) Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry, 36, 105–112.
Lowry, K. P., Dudley, T. K., Oddone, E. Z. (2005) Intentional and unintentional nonadherence to anti hypertensive medication. Annals of Pharmacotherapy, 39, 1198–1203.
MacLeod, M. S. & Sharp, D. M. (2001) Precursors of compliance with lithium treatment in affective disorders. Psychiatric Bulletin, 25, 183–186.
Maddox, J., Levi, M. & Thompson, C. (1994) The compliance with antidepressants in general practice. Journal of Psychopharmacology, 8, 48–53.
Maidment, R., Livingston, G. & Katona, C. (2002) Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. International Journal of Geriatric Psychiatry, 17, 752–757.
Makaryus, A. N. & Friedman, E. A. (2005) Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clinic Proceedings, 80, 991–994.
Makoul, G., Arntson, P. & Schofield, T. (1995) Health promotion in primary care: physician–patient communication and decision making about prescription medication. Social Science and Medicine, 41, 1241–1254.
Mitchell, A. J. (2006a) High medication discontinuation rates in psychiatry: how often is it understandable?
Journal of Clinical Psychopharmacology, 26, 109–112.
Mitchell, A. J. (2006b) Depressed patients and treatment adherence. Lancet, 367, 2041–2043.
Mitchell, A. J. (2007a) Adherence behaviour and psychotropic medication: is it a form of self-medication?
Medical Hypotheses, 68, 12–21.
Mitchell, A. J. & Selmes, T. (2007) Why don't patients attend their appointments? Maintaining engagement with psychiatric services. Advances in Psychiatric Treatment, 13, in press.
Mullins, C. D., Shaya, F. T., Meng, F.
et al (2005) Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy, 25, 660–667.
Nirodi, P. & Mitchell, A. J. (2002) The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Aging and Mental Health, 6, 191–196.
Nose, M., Barbui, C. & Tansella, M. (2003) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine, 33, 1149–1160.
O'Ceallaigh, S. & Fahy, T. (2001) Is there a role for the depot clinic in the modern management of schizophrenia?
Psychiatric Bulletin, 25, 481–484.
Olfson, M., Uttaro, T., Carson, W. H.
et al (2005) Male sexual dysfunction and quality of life in schizophrenia. Journal of Clinical Psychiatry, 66, 331–338.
Osterberg, L. & Blaschke, T. (2005) Adherence to medication. New England Journal of Medicine, 353, 487–497.
Pan, P. C. & Tantam, D. (1989) Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic. Acta Psychiatrica Scandinavica, 79, 564–570.
Patel, N., Crismon, M., Miller, A.
et al (2005) Drug adherence. Effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy, 25, 1242–1247.
Paykel, E. S., Hart, D. & Priest, R. G. (1998) Changes in public attitudes to depression during the Defeat Depression Campaign. British Journal of Psychiatry, 173, 519–522.
Perkins, D. O. (2002) Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry, 63, 1121–1128.
Piette, J. D., Heisler, M., Krein, S.
et al (2005) The role of patient–physician trust in moderating medication nonadherence due to cost pressures. Archives of Internal Medicine, 165, 1749–1755.
Rijcken, C. A., Tobi, H., Vergouwen, A. C.
et al (2004) Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data. Pharmacoepidemiology and Drug Safety, 13, 365–370.
Ritsner, M., Perelroyzen, G., Ilan, H.
et al (2004) Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. Journal of Clinical Psychopharmacology, 24, 245–254.
Rittmannsberger, H., Pachinger, T., Keppelmuller, P.
et al (2004) Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatric Services, 55, 174–179.
Robinson, D. G., Woerner, M. G., Alvir, J. M.
et al (2002) Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research, 57, 209–219.
Roose, S. P. (2003) Compliance: the impact of adverse events and tolerability on the physician's treatment decisions. European Neuropsychopharmacology, 13 (suppl. 3), S85–92.
Rosenberg, K. P., Bleiberg, K. L., Koscis, J.
et al (2003) A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. Journal of Sex and Marital Therapy, 29, 289–296.
Rosenheck, R., Cramer, J., Xu, W.
et al (1997) A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. New England Journal of Medicine, 337, 809–815.
Sannibale, C., Hurkett, P., van den Bossche, E.
et al (2003) Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients. Drug and Alcohol Review, 22, 181–190.
Scott, J. & Pope, M. (2002) Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. American Journal of Psychiatry, 159, 1927–1929.
Sirey, J. A., Bruce, M. L., Alexopoulos, G. S.
et al (2001) Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. American Journal of Psychiatry, 158, 479–481.
Sleath, B., Rubin, R. H. & Huston, S. A. (2003) Hispanic ethnicity, physician–patient communication, and antidepressant adherence. Comprehensive Psychiatry, 44, 198–204.
Smith, S. M., O'Keane, V. & Murray, R. (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. British Journal of Psychiatry, 181, 49–55.
Stevenson, F. A., Cox, K., Britten, N.
et al (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expectations, 7, 235–245.
Sullivan, G., Wells, K. B., Morgenstern, H.
et al (1995) Identifying modifiable risk factors for rehospitalization: a case–control study of seriously mentally ill persons in Mississippi. American Journal of Psychiatry, 152, 1749–1756.
Sullivan, S., Kreling, D. & Hazlet, T. (1990) Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. Journal of Research in Pharmaceutical Economics, 2, 19–33.
Svarstad, B. L., Shireman, T. & Sweeney, J. (2001) Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services, 52, 805–811.
Task Force for Compliance (1994) Noncompliance with Medications: An Economic Tragedy with Important Implications for Health Care Reform. National Pharmaceutical Council.
Thompson, C. & Pledger, L. (1993) Doctor–patient communication: is patient knowledge of medical terminology improving?
Health Communication, 5, 83–97.
Valenstein, M., Copeland, L. A., Blow, F. C.
et al (2002) Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40, 630–639.
Van Putten, T., Crumpton, E. & Yale, C. (1976) Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry, 33, 1443–1446.
Velligan, D. I., Lam, Y. W. F., Glahn, D. C.
et al (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin, 32, 724–742
Weiden, P. J., Mackell, J. A. & McDonnell, D. D. (2004a) Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research, 66, 51–57.
Weiden, P. J., Kozma, C., Grogg, A.
et al (2004b) Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services, 55, 886–891.
Wrigley, S., Jackson, H., Judd, F.
et al (2005) Role of stigma and attitudes toward help-seeking from a general practitioner for mental health problems in a rural town. Australian and New Zealand Journal of Psychiatry, 39, 514–521.
Yen, C. F., Chen, C. S., Ko, C. H.
et al (2005) Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry and Clinical Neurosciences, 59, 403–409.
Young, H. N., Bell, R. A., Epstein, R. M.
et al (2006) Types of information physicians provide when prescribing antidepressants. Journal of General Internal Medicine, 21, 1172–1177.
Zimmermann, U., Kraus, T., Himmerich, H.
et al (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. Journal of Psychiatric Research, 37, 193–220.